ArticleEuropean journal of nuclear medicine and molecular imaging2022

Usefulness of the 2-year iodine-123 metaiodobenzylguanidine-based risk model for post-discharge risk stratification of patients with acute decompensated heart failure.

Shunsuke Tamaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.